AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Charles River Laboratories International, Inc.
XNYS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG001S7Q271
345.37▲ 5.71 (1.68%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
339.66
Day's Range
332.17 – 347.20
52-Week Range
144.11 – 351.21
Volume
808.3K
Avg Volume
1.1M
Share Statistics
Shares Outstanding
Employees
19.7K
Exchange
XNYS
Listed
2000-06-23
Share count as of July 25, 2026

Charles River Laboratories International, Inc. (CRL) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Charles River Laboratories International, Inc. (CRL)
What is Charles River Laboratories International, Inc.'s Market Cap?
Charles River Laboratories International, Inc.'s Market Cap is $16.5B, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s Enterprise Value?
Charles River Laboratories International, Inc.'s Enterprise Value is $18.9B, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s Price / Sales?
Charles River Laboratories International, Inc.'s Price / Sales is 4.1×, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s EV / Revenue?
Charles River Laboratories International, Inc.'s EV / Revenue is 4.7×, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s EV / EBITDA?
Charles River Laboratories International, Inc.'s EV / EBITDA is 48.8×, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s Revenue (TTM)?
Charles River Laboratories International, Inc.'s Revenue (TTM) is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s Net Income (TTM)?
Charles River Laboratories International, Inc.'s Net Income (TTM) is -$238.5M, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s EBITDA?
Charles River Laboratories International, Inc.'s EBITDA is $388.0M, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s Diluted EPS (TTM)?
Charles River Laboratories International, Inc.'s Diluted EPS (TTM) is -5.00, based on as-reported figures from SEC (XBRL) filings.
What is Charles River Laboratories International, Inc.'s EBITDA Margin?
Charles River Laboratories International, Inc.'s EBITDA Margin is 9.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CRLAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 27, 2026Mar 28, 2026Dec 27, 2025Sep 27, 2025Jun 28, 2025Mar 29, 2025Dec 28, 2024Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 30, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Sep 24, 2022Jun 25, 2022
Total revenue
YoY growth-2.7%+1.2%-0.8%-0.5%+0.6%
Costs and expenses
Cost of revenue (excluding amortization of intangible assets)—————
Selling, general and administrative
Amortization of intangible assets
Operating income
% of revenue11.9%12.0%-28.5%13.3%9.7%
Other income (expense)
Interest income
Interest expense
Other (expense) income, net
Income before income taxes
Provision for income taxes
Net income (loss)
% of revenue-0.1%-1.5%-27.8%5.5%5.1%
Less: Net income attributable to noncontrolling interests
Net income (loss) attributable to common shareholders
% of revenue-0.1%-1.5%-27.8%5.4%5.1%
Basic (in dollars per share)
Diluted (in dollars per share)—